250 related articles for article (PubMed ID: 24509630)
1. A synthetic luciferin improves bioluminescence imaging in live mice.
Evans MS; Chaurette JP; Adams ST; Reddy GR; Paley MA; Aronin N; Prescher JA; Miller SC
Nat Methods; 2014 Apr; 11(4):393-5. PubMed ID: 24509630
[TBL] [Abstract][Full Text] [Related]
2. A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regions.
Simonyan H; Hurr C; Young CN
Physiol Genomics; 2016 Oct; 48(10):762-770. PubMed ID: 27614203
[TBL] [Abstract][Full Text] [Related]
3. A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.
Godinat A; Park HM; Miller SC; Cheng K; Hanahan D; Sanman LE; Bogyo M; Yu A; Nikitin GF; Stahl A; Dubikovskaya EA
ACS Chem Biol; 2013 May; 8(5):987-99. PubMed ID: 23463944
[TBL] [Abstract][Full Text] [Related]
4. Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging.
Berger F; Paulmurugan R; Bhaumik S; Gambhir SS
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2275-85. PubMed ID: 18661130
[TBL] [Abstract][Full Text] [Related]
5. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor.
Kim M; Gupta SK; Zhang W; Talele S; Mohammad AS; Laramy J; Mladek AC; Zhang S; Sarkaria JN; Elmquist WF
Drug Metab Dispos; 2022 Mar; 50(3):277-286. PubMed ID: 34887255
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Brightness and Spectral Properties of Click Beetle and Firefly Luciferases Using Luciferin Analogues: Identification of Preferred Pairings of Luciferase and Substrate for In Vivo Bioluminescence Imaging.
Zambito G; Gaspar N; Ridwan Y; Hall MP; Shi C; Kirkland TA; Encell LP; Löwik C; Mezzanotte L
Mol Imaging Biol; 2020 Dec; 22(6):1523-1531. PubMed ID: 32926287
[TBL] [Abstract][Full Text] [Related]
7. Aminoluciferins extend firefly luciferase bioluminescence into the near-infrared and can be preferred substrates over D-luciferin.
Mofford DM; Reddy GR; Miller SC
J Am Chem Soc; 2014 Sep; 136(38):13277-82. PubMed ID: 25208457
[TBL] [Abstract][Full Text] [Related]
8. Bioluminescence imaging in mice with synthetic luciferin analogues.
Ji X; Adams ST; Miller SC
Methods Enzymol; 2020; 640():165-183. PubMed ID: 32560797
[TBL] [Abstract][Full Text] [Related]
9. Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain.
Mezzanotte L; Aswendt M; Tennstaedt A; Hoeben R; Hoehn M; Löwik C
Contrast Media Mol Imaging; 2013; 8(6):505-13. PubMed ID: 24375906
[TBL] [Abstract][Full Text] [Related]
10. Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system.
Li S; Ruan Z; Zhang H; Xu H
Eur J Med Chem; 2021 Feb; 211():113111. PubMed ID: 33360804
[TBL] [Abstract][Full Text] [Related]
11. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
[TBL] [Abstract][Full Text] [Related]
12. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.
Inoue Y; Kiryu S; Izawa K; Watanabe M; Tojo A; Ohtomo K
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):771-9. PubMed ID: 19096841
[TBL] [Abstract][Full Text] [Related]
13. Organic anion transporter 1 (OAT1/SLC22A6) enhances bioluminescence based on d-luciferin-luciferase reaction in living cells by facilitating the intracellular accumulation of d-luciferin.
Furuya T; Takehara I; Shimura A; Kishimoto H; Yasujima T; Ohta K; Shirasaka Y; Yuasa H; Inoue K
Biochem Biophys Res Commun; 2018 Jan; 495(3):2152-2157. PubMed ID: 29273507
[TBL] [Abstract][Full Text] [Related]
14. Boosting bioluminescence neuroimaging: an optimized protocol for brain studies.
Aswendt M; Adamczak J; Couillard-Despres S; Hoehn M
PLoS One; 2013; 8(2):e55662. PubMed ID: 23405190
[TBL] [Abstract][Full Text] [Related]
15. Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo.
Adams ST; Miller SC
Curr Opin Chem Biol; 2014 Aug; 21():112-20. PubMed ID: 25078002
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Molecular Bioluminescence Imaging: New Tools and Applications.
Mezzanotte L; van 't Root M; Karatas H; Goun EA; Löwik CWGM
Trends Biotechnol; 2017 Jul; 35(7):640-652. PubMed ID: 28501458
[TBL] [Abstract][Full Text] [Related]
17. How to Select Firefly Luciferin Analogues for In Vivo Imaging.
Saito-Moriya R; Nakayama J; Kamiya G; Kitada N; Obata R; Maki SA; Aoyama H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673331
[TBL] [Abstract][Full Text] [Related]
18. Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging.
Yeh HW; Karmach O; Ji A; Carter D; Martins-Green MM; Ai HW
Nat Methods; 2017 Oct; 14(10):971-974. PubMed ID: 28869756
[TBL] [Abstract][Full Text] [Related]
19. ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.
Huang R; Vider J; Serganova I; Blasberg RG
Mol Imaging; 2011 Jun; 10(3):215-26. PubMed ID: 21496450
[TBL] [Abstract][Full Text] [Related]
20. Applications of luciferin biosynthesis: Bioluminescence assays for l-cysteine and luciferase.
Niwa K; Nakajima Y; Ohmiya Y
Anal Biochem; 2010 Jan; 396(2):316-8. PubMed ID: 19748476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
